What is the current annual EBITDA of CME?

As of today, CME annual EBITDA is $4.56B

What is 1-year change in CME annual EBITDA?

CME annual EBITDA is up +6.84% year-over-year

What is 3-year change in CME annual EBITDA?

CME annual EBITDA is up +34.98% over the past 3 years

How far is CME annual EBITDA from its all-time high?

CME annual EBITDA is currently at its all-time high

How does CME annual EBITDA rank versus sector peers?

CME annual EBITDA is higher than 92.56% of companies in Financial Services sector

When is CME next annual earnings release?

As of today, the next annual earnings release for CME has not been scheduled

What is the current quarterly EBITDA of CME?

As of today, CME quarterly EBITDA is $1.39B

What is CME quarterly EBITDA most recent change?

CME quarterly EBITDA was up +26.41% on March 31, 2026

What is 1-year change in CME quarterly EBITDA?

CME quarterly EBITDA is up +17.01% year-over-year

How far is CME quarterly EBITDA from its all-time high?

CME quarterly EBITDA is currently at its all-time high

How does CME quarterly EBITDA rank versus sector peers?

CME quarterly EBITDA is higher than 94.69% of companies in Financial Services sector

When is CME next earnings release?

The next earnings release for CME is on July 22, 2026

What is the current TTM EBITDA of CME?

As of today, CME TTM EBITDA is $4.76B

What is CME TTM EBITDA most recent change?

CME TTM EBITDA was up +4.44% on March 31, 2026

What is 1-year change in CME TTM EBITDA?

CME TTM EBITDA is up +7.91% year-over-year

How far is CME TTM EBITDA from its all-time high?

CME TTM EBITDA is currently at its all-time high

How does CME TTM EBITDA rank versus sector peers?

CME TTM EBITDA is higher than 95.51% of companies in Financial Services sector

When is CME next earnings release?

The next earnings release for CME is on July 22, 2026

CME Group Inc. (CME) EBITDA History & Chart Since 1999

Annual EBITDA

$4.56B$292.10M+6.84%

December 31, 2025

Summary

Current Value: As of today, CME annual EBITDA is $4.56B, up +6.84% on December 31, 2025
Historical Performance: CME annual EBITDA is up +34.98% over the past 3 years, up +47.02% over the past 5 years
All-Time High Comparison: CME annual EBITDA is currently at its all-time high
3-Year Low Comparison: CME annual EBITDA is +34.98% above its 3-year low of $3.38B reached on an earlier date
Sector Comparison: CME annual EBITDA is higher than 92.56% of companies in Financial Services sector

EBITDA Chart

Performance

CME Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$4.56B	+6.8%	+35.0%	+47.0%	+120.6%
Quarterly EBITDA	Mar 31, 26	$1.39B	+17.0%	+39.0%	+69.2%	+136.8%
TTM EBITDA	Mar 31, 26	$4.76B	+7.9%	+38.9%	+67.0%	+117.4%
Price	Jun 10, 26	$263.80	-2.2%	+42.7%	+23.0%	+391.7%
PE Ratio	Jun 10, 26	22.51	-17.0%	-4.1%	-44.0%	+46.9%
Annual Revenue	Dec 31, 25	$6.52B	+6.4%	+29.9%	+33.5%	+118.5%
Annual EPS	Dec 31, 25	$11.16	+15.4%	+50.9%	+90.1%	+289.9%
Annual EBIT	Dec 31, 25	$4.23B	+7.6%	+40.2%	+60.4%	+133.8%
Annual Net Income	Dec 31, 25	$4.04B	+14.6%	+50.0%	+92.0%	+324.7%

EBITDA Highs

CME Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$4.56B	Dec 31, 25	at high
5Y	$4.56B	Dec 31, 25	at high
All	$4.56B	Dec 31, 25	at high

EBITDA Lows

CME Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$3.38B	N/A	+35.0%
5Y	$3.03B	Dec 31, 21	+50.5%
All	$25.41M	Dec 31, 00	>+9999.0%

EBITDA History

Year	Value	Change
2025	$4.56B	+6.8%
2024	$4.27B	+12.7%
2023	$3.79B	+12.1%
2022	$3.38B	+11.5%
2021	$3.03B	-2.3%
2020	$3.10B	+0.9%
2019	$3.07B	+6.3%
2018	$2.89B	+14.9%
2017	$2.52B	+2.5%
2016	$2.46B	+11.3%
2015	$2.21B	+10.6%
2014	$2.00B	+6.9%
2013	$1.87B	-3.9%
2012	$1.94B	-14.8%

Year	Value	Change
2011	$2.28B	+10.3%
2010	$2.07B	+12.9%
2009	$1.83B	+1.1%
2008	$1.81B	+51.3%
2007	$1.20B	+98.5%
2006	$602.94M	+23.9%
2005	$486.46M	+15.4%
2004	$421.43M	+57.3%
2003	$267.88M	+32.1%
2002	$202.74M	+17.3%
2001	$172.88M	+580.5%
2000	$25.41M	-14.7%
1999	$29.79M	-

FAQ

What is the current annual EBITDA of CME?
As of today, CME annual EBITDA is $4.56B
What is 1-year change in CME annual EBITDA?
CME annual EBITDA is up +6.84% year-over-year
What is 3-year change in CME annual EBITDA?
CME annual EBITDA is up +34.98% over the past 3 years
How far is CME annual EBITDA from its all-time high?
CME annual EBITDA is currently at its all-time high
How does CME annual EBITDA rank versus sector peers?
CME annual EBITDA is higher than 92.56% of companies in Financial Services sector
When is CME next annual earnings release?
As of today, the next annual earnings release for CME has not been scheduled

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

Quarterly EBITDA

$1.39B$291.00M+26.41%

March 31, 2026

Summary

Current Value: As of today, CME quarterly EBITDA is $1.39B, up +26.41% on March 31, 2026
Historical Performance: CME quarterly EBITDA is up +17.01% year-over-year, up +38.97% over the past 3 years
All-Time High Comparison: CME quarterly EBITDA is currently at its all-time high
3-Year Low Comparison: CME quarterly EBITDA is +53.33% above its 3-year low of $908.50M reached on September 30, 2023
Sector Comparison: CME quarterly EBITDA is higher than 94.69% of companies in Financial Services sector

Performance

CME Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Mar 31, 26	$1.39B	+26.4%	+17.0%	+39.0%	+69.2%
Annual EBITDA	Dec 31, 25	$4.56B	–	+6.8%	+35.0%	+47.0%
TTM EBITDA	Mar 31, 26	$4.76B	+4.4%	+7.9%	+38.9%	+67.0%
Price	Jun 10, 26	$263.80	-13.0%	-2.2%	+42.7%	+23.0%
PE Ratio	Jun 10, 26	22.51	-17.2%	-17.0%	-4.1%	-44.0%
Quarterly Revenue	Mar 31, 26	$1.88B	+14.0%	+14.5%	+30.4%	+50.0%
Quarterly EPS	Mar 31, 26	$3.18	-2.0%	+21.3%	+30.9%	+98.5%
Quarterly EBIT	Mar 31, 26	$1.31B	+28.4%	+18.2%	+43.3%	+80.6%
Quarterly Net Income	Mar 31, 26	$1.17B	-0.5%	+23.0%	+33.1%	+103.2%

Quarterly EBITDA Highs

CME Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.39B	Mar 31, 26	at high
3Y	$1.39B	Mar 31, 26	at high
5Y	$1.39B	Mar 31, 26	at high
All	$1.39B	Mar 31, 26	at high

Quarterly EBITDA Lows

CME Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$1.06B	Sep 30, 25	+32.0%
3Y	$908.50M	Sep 30, 23	+53.3%
5Y	$709.90M	Sep 30, 21	+96.2%
All	$33.24M	Jun 30, 01	+4091.0%

Quarterly EBITDA History

Month	Value	Change
Mar 2026	$1.39B	+26.4%
Dec 2025	$1.10B	+4.4%
Sep 2025	$1.06B	-13.0%
Jun 2025	$1.21B	+1.9%
Mar 2025	$1.19B	+15.5%
Dec 2024	$1.03B	-7.0%
Sep 2024	$1.11B	+2.1%
Jun 2024	$1.08B	+3.8%
Mar 2024	$1.04B	+10.0%
Dec 2023	$949.50M	+4.5%
Sep 2023	$908.50M	-2.1%
Jun 2023	$927.90M	-7.4%
Mar 2023	$1.00B	+32.1%
Dec 2022	$758.90M	-8.4%
Sep 2022	$828.80M	-1.3%
Jun 2022	$839.80M	-11.7%
Mar 2022	$951.00M	+31.0%
Dec 2021	$726.20M	+2.3%
Sep 2021	$709.90M	-7.9%
Jun 2021	$771.20M	-6.3%
Mar 2021	$823.30M	+29.6%
Dec 2020	$635.50M	-1.2%
Sep 2020	$643.00M	-14.4%
Jun 2020	$750.80M	-30.0%
Mar 2020	$1.07B	+55.6%
Dec 2019	$689.20M	-14.5%
Sep 2019	$806.40M	-1.8%
Jun 2019	$821.00M	+10.3%
Mar 2019	$744.60M	+0.3%
Dec 2018	$742.60M	+23.0%
Sep 2018	$603.80M	-15.9%
Jun 2018	$718.00M	-9.4%
Mar 2018	$792.70M	+34.6%
Dec 2017	$588.90M	-4.8%
Sep 2017	$618.60M	-6.0%
Jun 2017	$658.00M	-11.2%
Mar 2017	$741.10M	+26.7%
Dec 2016	$585.00M	-1.4%
Sep 2016	$593.20M	-4.0%
Jun 2016	$617.70M	-6.2%
Mar 2016	$658.60M	+25.8%
Dec 2015	$523.50M	-8.4%
Sep 2015	$571.50M	+2.2%
Jun 2015	$559.30M	-0.5%
Mar 2015	$562.30M	+9.1%
Dec 2014	$515.40M	+6.2%
Sep 2014	$485.50M	+1.9%
Jun 2014	$476.30M	-7.9%
Mar 2014	$517.30M	+36.1%
Dec 2013	$380.00M	-17.1%

Month	Value	Change
Sep 2013	$458.50M	-19.0%
Jun 2013	$566.20M	+22.3%
Mar 2013	$462.80M	+6.5%
Dec 2012	$434.70M	-4.7%
Sep 2012	$456.30M	-14.5%
Jun 2012	$533.80M	+3.0%
Mar 2012	$518.40M	+13.7%
Dec 2011	$456.10M	-28.5%
Sep 2011	$637.50M	+6.4%
Jun 2011	$599.20M	+1.9%
Mar 2011	$588.20M	+14.4%
Dec 2010	$514.10M	+1.1%
Sep 2010	$508.40M	-12.3%
Jun 2010	$580.00M	+20.0%
Mar 2010	$483.40M	+2.8%
Dec 2009	$470.40M	+1.1%
Sep 2009	$465.10M	+0.9%
Jun 2009	$461.10M	+0.6%
Mar 2009	$458.20M	-7.9%
Dec 2008	$497.68M	-2.2%
Sep 2008	$508.87M	+34.3%
Jun 2008	$378.78M	-18.2%
Mar 2008	$462.97M	+20.8%
Dec 2007	$383.22M	+0.6%
Sep 2007	$380.86M	+75.9%
Jun 2007	$216.49M	-2.0%
Mar 2007	$220.98M	+42.8%
Dec 2006	$154.75M	-1.4%
Sep 2006	$156.95M	-2.9%
Jun 2006	$161.67M	+25.4%
Mar 2006	$128.95M	+13.8%
Dec 2005	$113.30M	-5.7%
Sep 2005	$120.09M	-10.2%
Jun 2005	$133.79M	+16.5%
Mar 2005	$114.88M	+6.2%
Dec 2004	$108.20M	-8.2%
Sep 2004	$117.87M	+7.7%
Jun 2004	$109.43M	+21.3%
Mar 2004	$90.24M	+38.2%
Dec 2003	$65.28M	-4.7%
Sep 2003	$68.46M	-41.4%
Jun 2003	$116.93M	+105.3%
Mar 2003	$56.97M	-13.7%
Dec 2002	$65.99M	+47.9%
Sep 2002	$44.61M	-7.1%
Jun 2002	$48.00M	+13.3%
Mar 2002	$42.38M	+17.3%
Dec 2001	$36.13M	-21.0%
Sep 2001	$45.72M	+37.5%
Jun 2001	$33.24M	-

FAQ

What is the current quarterly EBITDA of CME?
As of today, CME quarterly EBITDA is $1.39B
What is CME quarterly EBITDA most recent change?
CME quarterly EBITDA was up +26.41% on March 31, 2026
What is 1-year change in CME quarterly EBITDA?
CME quarterly EBITDA is up +17.01% year-over-year
How far is CME quarterly EBITDA from its all-time high?
CME quarterly EBITDA is currently at its all-time high
How does CME quarterly EBITDA rank versus sector peers?
CME quarterly EBITDA is higher than 94.69% of companies in Financial Services sector
When is CME next earnings release?
The next earnings release for CME is on July 22, 2026

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

TTM EBITDA

$4.76B$202.50M+4.44%

March 31, 2026

Summary

Current Value: As of today, CME TTM EBITDA is $4.76B, up +4.44% on March 31, 2026
Historical Performance: CME TTM EBITDA is up +7.91% year-over-year, up +38.86% over the past 3 years
All-Time High Comparison: CME TTM EBITDA is currently at its all-time high
3-Year Low Comparison: CME TTM EBITDA is +38.86% above its 3-year low of $3.43B reached on an earlier date
Sector Comparison: CME TTM EBITDA is higher than 95.51% of companies in Financial Services sector

Performance

CME Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Mar 31, 26	$4.76B	+4.4%	+7.9%	+38.9%	+67.0%
Annual EBITDA	Dec 31, 25	$4.56B	–	+6.8%	+35.0%	+47.0%
Quarterly EBITDA	Mar 31, 26	$1.39B	+26.4%	+17.0%	+39.0%	+69.2%
Price	Jun 10, 26	$263.80	-13.0%	-2.2%	+42.7%	+23.0%
PE Ratio	Jun 10, 26	22.51	-17.2%	-17.0%	-4.1%	-44.0%
TTM Revenue	Mar 31, 26	$6.76B	+3.6%	+7.5%	+32.1%	+46.5%
TTM EPS	Mar 31, 26	$11.72	+5.0%	+17.8%	+48.9%	+119.6%
TTM EBIT	Mar 31, 26	$4.43B	+4.8%	+8.6%	+44.3%	+84.4%
TTM Net Income	Mar 31, 26	$4.26B	+5.4%	+17.4%	+48.6%	+122.6%

TTM EBITDA Highs

CME TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$4.76B	Mar 31, 26	at high
3Y	$4.76B	Mar 31, 26	at high
5Y	$4.76B	Mar 31, 26	at high
All	$4.76B	Mar 31, 26	at high

TTM EBITDA Lows

CME TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$4.41B	N/A	+7.9%
3Y	$3.43B	N/A	+38.9%
5Y	$2.85B	N/A	+67.0%
All	$33.24M	Jun 30, 01	>+9999.0%

TTM EBITDA History

Month	Value	Change
Mar 2026	$4.76B	+4.4%
Dec 2025	$4.56B	+1.6%
Sep 2025	$4.49B	-1.2%
Jun 2025	$4.54B	+2.9%
Mar 2025	$4.41B	+3.4%
Dec 2024	$4.27B	+1.9%
Sep 2024	$4.19B	+5.0%
Jun 2024	$3.99B	+4.1%
Mar 2024	$3.83B	+1.1%
Dec 2023	$3.79B	+5.3%
Sep 2023	$3.60B	+2.3%
Jun 2023	$3.52B	+2.6%
Mar 2023	$3.43B	+1.5%
Dec 2022	$3.38B	+1.0%
Sep 2022	$3.35B	+3.7%
Jun 2022	$3.23B	+2.2%
Mar 2022	$3.16B	+4.2%
Dec 2021	$3.03B	+3.1%
Sep 2021	$2.94B	+2.3%
Jun 2021	$2.87B	+0.7%
Mar 2021	$2.85B	-8.0%
Dec 2020	$3.10B	-1.7%
Sep 2020	$3.16B	-4.9%
Jun 2020	$3.32B	-2.1%
Mar 2020	$3.39B	+10.7%
Dec 2019	$3.06B	-1.7%
Sep 2019	$3.11B	+7.0%
Jun 2019	$2.91B	+3.7%
Mar 2019	$2.81B	-1.7%
Dec 2018	$2.86B	+5.7%
Sep 2018	$2.70B	-0.5%
Jun 2018	$2.72B	+2.3%
Mar 2018	$2.66B	+2.0%
Dec 2017	$2.61B	+0.1%
Sep 2017	$2.60B	+1.0%
Jun 2017	$2.58B	+1.6%
Mar 2017	$2.54B	+3.4%
Dec 2016	$2.45B	+2.6%
Sep 2016	$2.39B	+0.9%
Jun 2016	$2.37B	+2.5%
Mar 2016	$2.31B	+4.3%
Dec 2015	$2.22B	+0.4%
Sep 2015	$2.21B	+4.1%
Jun 2015	$2.12B	+4.1%
Mar 2015	$2.04B	+2.3%
Dec 2014	$1.99B	+7.3%
Sep 2014	$1.86B	+1.5%
Jun 2014	$1.83B	-4.7%
Mar 2014	$1.92B	+2.9%
Dec 2013	$1.87B	-2.8%

Month	Value	Change
Sep 2013	$1.92B	+0.1%
Jun 2013	$1.92B	+1.7%
Mar 2013	$1.89B	-2.9%
Dec 2012	$1.94B	-1.1%
Sep 2012	$1.96B	-8.4%
Jun 2012	$2.15B	-3.0%
Mar 2012	$2.21B	-3.1%
Dec 2011	$2.28B	-2.5%
Sep 2011	$2.34B	+5.8%
Jun 2011	$2.21B	+0.9%
Mar 2011	$2.19B	+5.0%
Dec 2010	$2.09B	+2.1%
Sep 2010	$2.04B	+2.2%
Jun 2010	$2.00B	+6.3%
Mar 2010	$1.88B	+1.4%
Dec 2009	$1.85B	-1.4%
Sep 2009	$1.88B	-2.3%
Jun 2009	$1.93B	+4.5%
Mar 2009	$1.84B	-0.3%
Dec 2008	$1.85B	+6.6%
Sep 2008	$1.73B	+8.0%
Jun 2008	$1.61B	+11.2%
Mar 2008	$1.44B	+20.1%
Dec 2007	$1.20B	+23.5%
Sep 2007	$973.08M	+29.9%
Jun 2007	$749.17M	+7.9%
Mar 2007	$694.35M	+15.3%
Dec 2006	$602.33M	+7.4%
Sep 2006	$560.88M	+7.0%
Jun 2006	$524.01M	+5.6%
Mar 2006	$496.13M	+2.9%
Dec 2005	$482.06M	+1.1%
Sep 2005	$476.96M	+0.5%
Jun 2005	$474.73M	+5.4%
Mar 2005	$450.37M	+5.8%
Dec 2004	$425.74M	+11.2%
Sep 2004	$382.81M	+14.8%
Jun 2004	$333.41M	-2.2%
Mar 2004	$340.91M	+10.8%
Dec 2003	$307.64M	-0.2%
Sep 2003	$308.34M	+8.4%
Jun 2003	$284.49M	+32.0%
Mar 2003	$215.56M	+7.3%
Dec 2002	$200.97M	+17.4%
Sep 2002	$171.12M	-0.6%
Jun 2002	$172.22M	+9.4%
Mar 2002	$157.46M	+36.8%
Dec 2001	$115.08M	+45.8%
Sep 2001	$78.96M	+137.5%
Jun 2001	$33.24M	-

FAQ

What is the current TTM EBITDA of CME?
As of today, CME TTM EBITDA is $4.76B
What is CME TTM EBITDA most recent change?
CME TTM EBITDA was up +4.44% on March 31, 2026
What is 1-year change in CME TTM EBITDA?
CME TTM EBITDA is up +7.91% year-over-year
How far is CME TTM EBITDA from its all-time high?
CME TTM EBITDA is currently at its all-time high
How does CME TTM EBITDA rank versus sector peers?
CME TTM EBITDA is higher than 95.51% of companies in Financial Services sector
When is CME next earnings release?
The next earnings release for CME is on July 22, 2026

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

Data Sources & References

CME Official Website www.cmegroup.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1156375/000115637526000006/0001156375-26-000006-index.htm
CME Profile on Yahoo Finance finance.yahoo.com/quote/CME
CME Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cme